Agonistic anti-β1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the β1-adrenergic receptor expression in neonatal rat cardiomyocytes

Circulation

Volumn 98, Issue 22, 1998, Pages 2470-2476

  Podlowski, Svenia ^b   Luther, Hans Peter ^b   Morwinski, Rosemarie ^b   Müller, Johannes ^b   Wallukat, Gerd ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b NONE

Author keywords

Antibodies; Cardiomyopathy; Heart failure; Myocytes; Receptors, adrenergic, beta

Indexed keywords

AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BISOPROLOL; PROPRANOLOL DERIVATIVE; ANTIBODY; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CARDIOMYOPATHY; DOSE RESPONSE; DOWN REGULATION; GENE EXPRESSION; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RECEPTOR BINDING; STATISTICAL ANALYSIS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CONGESTIVE CARDIOMYOPATHY; CYTOLOGY; DRUG EFFECT; GENETICS; HEART MUSCLE; HUMAN; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WISTAR RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; AUTOANTIBODIES; BLOTTING, WESTERN; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; HUMANS; ISOPROTERENOL; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032217037     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.22.2470     Document Type: Article

References (36)

1. Schultheiss H-P. Immunological analysis of autoantibodies against the adenine nucleoticle translocator in dilated cardiomyopathy. J Mol Cell Cardiol. 1985;17:603-612.
2. Maisch B, Wedeking U, Kochsiek K. Quantitative assessment of anti-laminin antibodies in myocarditis and perimyocarditis. Eur Heart J. 1987;8(suppl I):233-235.
3. Rose NR, Beisel KW, Herskowitz A, Neu N, Wolfgram LJ, Traystman MD, Craig SW. Cardiac myosin and autoimmune myocarditis. Ciba Found Symp. 1987;129:3-24.
4. Wallukat G, Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic β-adrenergic function in cultured rat heart myocytes. Biomed Biochim Acta. 1987;78:634-639.
5. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoceptor in human idiopathic dilated cardiomyopathy. Circ Res. 1989;64:97-103.
6. Bristow MR, Ginsburg R, Minobe WA, Cubicciotti RS, Sagemann WS, Laurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
7. Kaumann AJ, Lemoine H, Schwederski-Menke U, Ehle B. Relations between β-adrenoceptor occupancy and increases of contractile force and adenylate cyclase activity induced by catecholamines in human ventricular myocardium. Naunyn Schmiedehergs Arch Pharmacol. 1989;339:99-112.
8. Bristow MR, Sandoval AB, Gilbert EM, Deisher T, Minobe WA, Rasmussen R, Myocardial α-, and β-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? Eur Heart J. 1988;9(suppl H):35-40.
9. iα, in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 1990;82:1249-1265.
10. 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
11. 1-adrenergic receptor in the failing human heart. Circulation. 1993;87:454-463.
12. Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman A.M. Reduced beta (1) receptor messenger-RNA abundance in the failing human heart. J Clin Invest. 1993;92:2737-2745.
13. Brodde O-E. Beta-adrenoceptors in cardiac disease. Pharmacol Ther. 1993;60:405-430.
14. 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol. 1996;27:146-154.
15. Wallukat G, Morwinski R, Kowal K, Förster A, Boewer V, Wollenberger A. Autoamibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J. 1991;12(suppl D):178-181.
16. Dorffel WV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P. Short-term hemodynamic effect of immunoadsorption in dilated cardiomyopathy. Circulation. 1997;95:1994-1997.
17. Müller J, Wallukat G, Weng Y-G, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542-549.
18. Halle W, Wollenberger A. Differenliation and behavior of isolated embryonic and neonatal heart cells in a chemically defined medium. Am J Cardiol. 1970;25:292-299.
19. Kössler A. Myosingehalt und Aktivierung der Kreatinphosphokinase in Rattenherz-Zellkulturen. Acta Biol Med Ger. 1972;29:119-134.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
22. 1-adrenergic receptor gene. J Biol Chem. 1990;265:12960-12965.
23. Jiang L, Kunos G. Sequence of the 5′regulatory domain of the gene encoding the rat beta 2-adrenergic receptor. Gene. 1995;163:331-332.
24. 2 receptor subtypes demonstrated by pholoaffinity labeling. J Biol Chem. 1983;258:8443-8449.
25. 1-adrenergic receptor. J Biol Chem. 1984;259:1344-1350.
26. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem. 1996;271:16384-16392.
27. George ST, Ruoho AE, Malbon CC. N-Glycosylation in expression and function of β-adrenergic receptors. J Biol Chem. 1986;261:16559-16564.
28. Hadcock JR, Malbon CD. Down-regulation of β-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA. 1988;85:5021-5025.
29. 2-adrenergic receptor mRNA in C6 glioma cells. Biochem Biophys Res Commun. 1990;170:46-52.
30. Dangel V, Giray J, Ratge D, Wisser H. Regulation of β-adrenoceptor density and mRNA levels in the cell line H9c2. Biochem J. 1996;317: 925-931.
31. Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw Hill: 1996:210-212.
32. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarrson Å. Long-term β-blockade in dilated cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation. 1989;80:551-563.
33. Hough C, Fukamauchi F, Chuang DM. Regulation of beta-adrenergic receptor mRNA in rat C6 glioma cells is sensitive to the state of microtubule assembly. J Neurochem. 1994;62:421-430.
34. Jasper JR, Post SR, Desai KH, Insel PA, Bernstein D. Colchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions. J Pharmacol Exp Ther. 1995;274:937-942.
35. 2+ overload. Circ Res. 1994;75:324-334.
36. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest. 1995;96:99-106.